Live tape
Top 8, mentions 7d29,253NVDA13,836 mentions▲ +0.04ANT4,206 mentions▲ +0.07GOOGL2,999 mentions▲ +0.04SPY2,296 mentions▲ +0.05QQQ1,811 mentions▲ +0.04SPCX1,568 mentions▲ +0.07AMD1,366 mentions▲ +0.06AAPL1,171 mentions▲ +0.04

Equity · Healthcare

TEVJF

OTC MARKETS OTCPK

Teva Pharmaceutical Industries (TEVJF)

Teva Pharmaceutical Industries Limited price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Revenue, year to Dec 2025
17.3B USD
EPS, diluted, year to Dec 2025
1.21 USD

Which funds hold Teva Pharmaceutical Industries (TEVJF)?

12 of the 45 institutional funds we track reported a Teva Pharmaceutical Industries position for the quarter ended 30 Sep 2026 — a combined 584.3M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Teva Pharmaceutical Industries (TEVJF)?
FundPositionSharesValueShares q/q
Glenview Capital ManagementNew position7,566,877299.6M USD
Marshall WaceNew position2,782,756110.2M USD
Millennium ManagementNew position1,465,71658.0M USD
Bridgewater AssociatesNew position982,87338.9M USD
Citadel AdvisorsNew position766,16730.3M USD
Tudor Investment CorpNew position440,00017.4M USD
D. E. Shaw & Co.New position205,8408.2M USD
Two Sigma InvestmentsNew position193,2877.7M USD
AQR Capital ManagementNew position144,6345.7M USD
Man GroupNew position72,2112.9M USD

Showing the 10 largest of 12 reported positions. The figures above count all of them.

What has been filed or recorded for Teva Pharmaceutical Industries (TEVJF)?

The filings we hold for Teva Pharmaceutical Industries, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Jun 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Teva Pharmaceutical Industries (TEVJF)?
And
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.49 USD
30 Jun 2026FinancialsTotal assets39.9B USDat period end
30 Jun 2026FinancialsTotal equity7.8B USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.31 USD
31 Dec 2025Annual reportFY 2025 reportedEPS 1.21 USDRevenue $1.50B
31 Dec 2025FinancialsRevenue17.3B USDfiscal year
31 Dec 2025FinancialsNet income1.4B USDfiscal year
31 Dec 2025FinancialsDiluted EPS1.21 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.37 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.24 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.18 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.45 USD
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.39 USD

What do people ask about Teva Pharmaceutical Industries (TEVJF)?

From live data
What is Teva Pharmaceutical Industries’ revenue?17.3B

Teva Pharmaceutical Industries reported revenue of 17.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Which funds own Teva Pharmaceutical Industries?12 of 45

12 of the 45 funds we track reported a Teva Pharmaceutical Industries position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Glenview Capital Management, Marshall Wace and Millennium Management. See Funds

When did Teva Pharmaceutical Industries last report earnings?−0.49

Teva Pharmaceutical Industries last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.49 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. TradingViewthe price chart widget, drawn by TradingView from their own data
  2. SEC EDGAR13F filings
  3. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  4. SEC EDGARreported earnings figures and scheduled report dates
  5. Company websiteAbout text: the company's own website, summarised in our own words